Skip to main content

Table 3 Plasma metabolites significantly (p < 0.05) associated with baseline ht-TKV. Effect size represents the magnitude and direction (+/−) of association between a given metabolite and ht-TKV, estimated by linear regression, while controlling for the selected HALT covariates, age, sex, genotype, site of sample collection, and BMI

From: Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course

Metabolite

Effect Size (SD)

p-value

FDR q-value

KEGG ID

PubChem ID

pseudo uridine

0.2273 (0.082)

0.0061

0.3375

C02067

15,047

aminomalonate

0.1240 (0.047)

0.0094

0.3375

C00872

100,714

Taurine

−0.0577 (0.024)

0.0151

0.3375

C00245

1123

Tyrosine

−0.1984 (0.082)

0.0156

0.3375

C00082

6057

isothreonic acid

0.1333 (0.055)

0.0166

0.3375

C21649

151,152

glutamic acid

−0.1111 (0.048)

0.0217

0.3677

C00025

33,032

indole-3-lactate

0.1544 (0.070)

0.0273

0.3965

C02043

92,904

myo-inositol

0.1080 (0.052)

0.0373

0.4075

C00137

892

2-hydroxybutanoic acid

−0.0940 (0.045)

0.0384

0.4075

C05984

440,864

Beta-D-fucose

0.0913 (0.046)

0.0482

0.4075

C02095

439,650